Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

ANALYSIS OF INDUCTION PHASE GLUCOCORTICOID USE ON ADRENAL SUPPRESSION IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Folia Medica Indonesiana · Vol. 52 No. 1 (2017) · hlm. 7–7

DOI
10.20473/fmi.v52i1.5197
ISSN
2355-8393, 2599-056X
Terbit
2017-08-08
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Glucocorticoids play an important role in the treatment of acute lymphoblastic leukemia (ALL). However, supraphysiological doses may cause suppression of the adrenal. Adrenal suppression resulting in reduced cortisol response may cause an inadequate host defence against infections, which remains a cause of morbidity and mortality in children with ALL. The occurrence of adrenal suppression before and after glucocorticoid therapy for childhood ALL is unclear. The aim of this study is to analysis the effect of glucocorticoid on cortisol levels during induction phase chemotherapy in children with acute lymphoblastic leukemia. A cross-sectional, observational prospective study was conducted to determine the effect of glucocorticoid on cortisol levels in children with acute lymphoblastic leukemia. Patients who met inclusion criteria were given dexamethasone or prednisone therapy for 49 days according to the 2013 Indonesian Chemotherapy ALL Protocol. Cortisol levels were measured on days 0, 14, 28, 42 and 56 of induction phase chemotherapy. There were 24 children, among 31 children recruited, who suffered from acute lymphoblastic leukemia. Before treatment, the means of cortisol levels were 228.95 ng/ml in standard risk group (prednisone) and 199.67 ng/ml in high risk group (dexamethasone). In standard risk group, the adrenal suppression occurs at about day 56. There was a significant decrement of cortisol levels in high risk group in days 14, 28, 42 against days 0 of induction phase (p=0.001). Both groups displayed different peak cortisol levels after 6 week of induction phase (p=0.028). Dexamethasone resulted in lower cortisol levels than prednisone during induction phase chemotherapy in children with acute lymphoblastic leukemia.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 86 tautan kepenulisan bersama · 33 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • RSUD Prof. Dr. Saiful Anwar Malang
  • University of Brawijaya
  • State University of Semarang
  • Rumah Sakit Umum Haji Surabaya
  • Poltekkes Kemenkes Malang
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Siti MuafifahState University of Semarang2
Didik HasmonoUniversitas Airlangga2
Nun ZairinaRumah Sakit Dokter Soetomo2
Bambang PermonoRumah Sakit Dokter Soetomo2
Mia Ratwita AndarsiniUniversitas Airlangga2
Levana RismayantiUniversitas Airlangga2
Dessy Surya SetyaniUniversitas Airlangga2
Ninik AsmaningsihRumah Sakit Dokter Soetomo2
Binti MuzayyanahUniversitas Airlangga1
Nuraida WisudaniAfiliasi tidak diketahui1
Eddy Zarkaty MRumah Sakit Umum Haji Surabaya1
Teri Wina HerwatiUniversitas Airlangga1
Budi SupraptiUniversitas Airlangga1
Mida PurwiningtyasUniversitas Airlangga1
Bayu Dharma SantiAfiliasi tidak diketahui1
Desantika WuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Bagus Putu Putra SuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Soedarsono SoedarsonoRumah Sakit Dokter Soetomo1
Herni SetyawatiUniversitas Airlangga1
Umi FatmawatiRumah Sakit Dokter Soetomo1
Febriansyah Nur UtomoRumah Sakit Dokter Soetomo1
Nur OktaviaUniversitas Airlangga1
Unedo Hence Markus SihombingAfiliasi tidak diketahui1
Hendriette Irene MamoUniversitas Airlangga1
Darto SaharsoRumah Sakit Dokter Soetomo1
Melawati OlevianingrumAfiliasi tidak diketahui1
Susanto NugrohoUniversity of Brawijaya1
Sri WinarsihRSUD Prof. Dr. Saiful Anwar Malang1
Reta Anggraeni WidyaUniversitas Airlangga1
Suharjono SuharjonoUniversity of Brawijaya1
Ekanita DesianiUniversitas Airlangga1
Dwi Hari SusiloUniversitas Airlangga1
Siti AsiyahPoltekkes Kemenkes Malang1
Yulistiani YulistianiAfiliasi tidak diketahui1
I Dewa Gede UgrasenaUniversitas Airlangga1
Adinugraha AmarullahUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">ANALYSIS OF INDUCTION PHASE GLUCOCORTICOID USE ON ADRENAL SUPPRESSION IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA</dc:title><dc:creator>Octaviana Maria Simbolon</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>I Dg Ugrasena</dc:creator><dc:creator>Mariyatul Qibtiyah</dc:creator><dc:subject>acute lymphoblastic leukemia</dc:subject><dc:subject>glucocorticoids</dc:subject><dc:subject>adrenal suppression</dc:subject><dc:subject>cortisol levels</dc:subject><dc:subject>induction chemotherapy</dc:subject><dc:subject>dexamethasone</dc:subject><dc:subject>prednisone</dc:subject><dc:subject>pediatric leukemia</dc:subject><dc:subject>infection risk</dc:subject><dc:description xml:lang="en">Glucocorticoids play an important role in the treatment of acute lymphoblastic leukemia (ALL). However, supraphysiological doses may cause suppression of the adrenal. Adrenal suppression resulting in reduced cortisol response may cause an inadequate host defence against infections, which remains a cause of morbidity and mortality in children with ALL. The occurrence of adrenal suppression before and after glucocorticoid therapy for childhood ALL is unclear. The aim of this study is to analysis the effect of glucocorticoid on cortisol levels during induction phase chemotherapy in children with acute lymphoblastic leukemia. A cross-sectional, observational prospective study was conducted to determine the effect of glucocorticoid on cortisol levels in children with acute lymphoblastic leukemia. Patients who met inclusion criteria were given dexamethasone or prednisone therapy for 49 days according to the 2013 Indonesian Chemotherapy ALL Protocol. Cortisol levels were measured on days 0, 14, 28, 42 and 56 of induction phase chemotherapy. There were 24 children, among 31 children recruited, who suffered from acute lymphoblastic leukemia. Before treatment, the means of cortisol levels were 228.95 ng/ml in standard risk group (prednisone) and 199.67 ng/ml in high risk group (dexamethasone). In standard risk group, the adrenal suppression occurs at about day 56. There was a significant decrement of cortisol levels in high risk group in days 14, 28, 42 against days 0 of induction phase (p=0.001). Both groups displayed different peak cortisol levels after 6 week of induction phase (p=0.028). Dexamethasone resulted in lower cortisol levels than prednisone during induction phase chemotherapy in children with acute lymphoblastic leukemia.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-08</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v52i1.5197</dc:identifier><dc:identifier>10.20473/fmi.v52i1.5197</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 52 No 1 (2017); 7-7</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5197/3312</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>